Back to News
investment

Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results

Business Wire
Loading...
5 min read
0 likes
⚡ Quantum Brief
Covalon Technologies Ltd., a Mississauga-based advanced medical technology company, will release its Q1 Fiscal 2026 financial results on February 25, 2026, before markets open. A conference call and webcast to discuss the results will be held the same day at 8:30 AM ET, accessible via phone or online link, with a Q&A session for participants. The company specializes in wound care, vascular access, and surgical products aimed at reducing infections and improving patient outcomes, trading on TSXV (COV) and OTCQX (CVALF). Recorded materials, including financial statements, will be available on Covalon’s website and SEDAR PLUS following the call for investor reference. Forward-looking statements in the release carry risks, with the company disclaiming responsibility for updates unless legally required.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (28).png
Quantum News · Media Library

This section is Partnership Content suppliedThe content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Article contentMISSISSAUGA, Ontario — Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q1 Fiscal 2026 results on Wednesday, February 25, 2026, before markets open. A conference call and webcast to discuss the results will be held on Wednesday, February 25, 2026, at 8:30am ET.Sign In or Create an AccountEmail AddressContinueor View more offersArticle contentTo view, listen to, and participate in the live webcast, please follow the link below:Article contentWe apologize, but this video has failed to load.Try refreshing your browser, ortap here to see other videos from our team.Article contenthttps://events.q4inc.com/attendee/620262525Article contentArticle contentTo listen and participate via the conference call, please dial:Article contentTop StoriesGet the latest headlines, breaking news and columns.There was an error, please provide a valid email address.Sign UpBy signing up you consent to receive the above newsletter from Postmedia Network Inc.Thanks for signing up!A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againInterested in more newsletters? Browse here.Article contentNorth American Toll-Free: 1-800-549-8228 Local (Toronto): 289-819-1520 Local (New York): 646-564-2877 Conference ID: 56849Article contentParticipants will be able to ask questions during the Q&A portion of the conference call either by asking them on the call or by submitting them using the chat function on the webcast.Article contentA recording of the call will be available on www.covalon.com under News & Events on the Investors tab.Article contentCopies of Covalon’s financial statements and MD&A can be obtained on SEDAR PLUS at www.sedarplus.ca and under SEDAR Filings on the Investors tab of Covalon’s website.Article contentThose interested in learning about Covalon’s solutions may visit www.covalon.com or follow Covalon on LinkedIn, Facebook, Instagram, or X.Article contentAbout Covalon Article contentCovalon is a leading MedTech company dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. Our expertise spans advanced wound care, vascular access, and surgical consumables, with a strong focus on enhancing healing, reducing healthcare-associated infections (HAIs), and protecting skin integrity. Our solutions are designed for patients and made for care providers. The Company is listed on the TSX Venture Exchange (COV) and trades on the OTCQX Market (CVALF). To learn more about Covalon, visit our website atArticle contentwww.covalon.comArticle content.Article contentNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Article contentThis news release may contain forward-looking statements which reflect the Company’s current expectations regarding future events. The forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “plan”, “estimate”, “expect”, “intend”, or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur”, or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts, but instead represent management’s expectations, estimates, and projections regarding future events. Forward-looking statements involve risks and uncertainties, including, but not limited to, the factors described in greater detail in the “Risks and Uncertainties” section of our management’s discussion and analysis of financial condition and results of operations for the year ended September 30, 2024, which is available on the Company’s profile at Article contentArticle contentwww.sedarplus.caArticle content, any of which could cause results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. Investors should not place undue reliance on any forward-looking statements. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company assumes no obligation to update or alter any forward-looking statements, whether as a result of new information, further events, or otherwise, except as required by law.Article contentArticle contentArticle contentArticle contentView source version on businesswire.com: Article content https://www.businesswire.com/news/home/20260219918156/en/Article contentArticle contentContactsArticle contentTo learn more about Covalon, please contact: Brent Ashton, Chief Executive Officer, Covalon Technologies Ltd. Email: investors@covalon.com Phone: 1.877.711.6055 Website: https://covalon.com/#distroArticle contentTrending Garry Marr: For young Canadians who bought at peak of market, Home Buyers' Plan was invitation to disaster First-Time Homebuyers Private equity is having a baby and it might just be yours Economy Cooler inflation gives Bank of Canada an opening to cut rates if economy falters, say economists Economy Stellantis Canada CEO says sale of Ontario battery plant was due to poor EV demand Commodities Posthaste: Canada's biggest city is losing momentum, and that's a problem for the whole country News Share this article in your social networkCommentsYou must be logged in to join the discussion or read more comments.Create an AccountSign in Join the Conversation Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information. Garry Marr: For young Canadians who bought at peak of market, Home Buyers' Plan was invitation to disaster First-Time Homebuyers Private equity is having a baby and it might just be yours Economy Cooler inflation gives Bank of Canada an opening to cut rates if economy falters, say economists Economy Stellantis Canada CEO says sale of Ontario battery plant was due to poor EV demand Commodities Posthaste: Canada's biggest city is losing momentum, and that's a problem for the whole country News

Read Original

Tags

partnership

Source Information

Source: Financial Post

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.